MedTrace Logo

Transparent Cap-assisted Endoscopic Sclerotherapy

NCT02361593 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2017-01-16

No results posted yet for this study

Summary

The aim of this study is to evaluate efficacy and safety of transparent cap-assisted endoscopic sclerotherapyI(lauromacrogol injection) in management of esophageal varices.

Conditions

  • Esophageal Varices

Interventions

PROCEDURE

assistance of a transparent cap

Patients will receive endoscopic injection of lauromacrogol with assistance of a transparent cap.

PROCEDURE

without a transparent cap

Patients will receive routine endoscopic injection of lauromacrogol without use of transparent cap.

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Shiyao CHEN, M.D. · Zhongshan Hospital, Shanghai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
76 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-05-31
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02361593 on ClinicalTrials.gov